WPG Advisers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
TAM
SI
WPG Advisers's NVS Position: Q2 2026 in Review
WPG Advisers increased its Novartis (NVS) stake by 17% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,053 shares worth $165K. The position accounts for 0.1% of the portfolio, ranked #123.
WPG Advisers first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- WPG Advisers held 1,053 shares of Novartis worth $165K as of Q2 2026.
- WPG Advisers bought 150 Novartis shares in Q2 2026, an estimated $22.5K.
- Novartis made up 0.1% of WPG Advisers's portfolio in Q2 2026, its #123 holding.
- WPG Advisers first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
- 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.